|
After adjusting for differences in patient characteristics, no significant differences were observed between BluePro and AMO/Somnodent groups in any of the primary outcome measures (see figure above).
In addition, there was no significant difference between the groups in self-reported measures of treatment satisfaction and compliance (see figure below).
|
